Vortioxetine-Induced Amenorrhea: A Case Report.
Clin Neuropharmacol
; 45(1): 7-8, 2022.
Article
de En
| MEDLINE
| ID: mdl-35029863
ABSTRACT
BACKGROUND:
Vortioxetine is a novel multimodal antidepressant for the treatment of major depressive disorders and is widely used in clinical practice. Vortioxetine has a safe profile. However, there are case reports of other adverse effects in the literature. In this article, a case of amenorrhea due to vortioxetine is presented. CASE The patient is 36 years old, married, female, and is an anesthesiologist. She applied to the psychiatric outpatient clinic with symptoms of major depression. Vortioxetine was initiated at 10 mg/d and then gradually increased to 20 mg/d. She had regular menstruation until now. However, she did not menstruate after taking vortioxetine. The patient used vortioxetine for 3 months and never had a period. Pregnancy test and other tests to investigate organic etiology were normal. Two weeks after discontinuation of vortioxetine, the patient had a menstrual period.CONCLUSIONS:
Further research is needed on the relationship and possible mechanisms between vortioxetine and amenorrhea.
Texte intégral:
1
Collection:
01-internacional
Base de données:
MEDLINE
Sujet principal:
Trouble dépressif majeur
Limites:
Adult
/
Female
/
Humans
Langue:
En
Journal:
Clin Neuropharmacol
Année:
2022
Type de document:
Article
Pays d'affiliation:
Turquie